In a new study published in Lupus Science & Medicine, researchers assessed clinical trial perceptions among a predominantly Black cohort of participants with systemic lupus erythematosus (SLE).

The U.S. Food and Drug Administration (FDA has cleared the investigational new drug (IND) application for Allogene ...

A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can minimize flare risk and support the successful discontinuation of GCs in ...

The Phase 1 GALLOP study evaluating the investigational therapy, CB-010, for treatment of lupus nephritis has launched.

Explore our lupus resources in English, Spanish, and Chinese. The Lupus Foundation of America, as Secretariat of the World Lupus Federation (WLF), provides various resources for WLF member ...

Nyobie’s journey with lupus is a story of resilience, empowerment, and the transformative strength of finding her voice. Diagnosed in 2010 after a difficult 19-year journey through eight different ...

The way we talk about lupus – to ourselves and with others – matters. Living with lupus can feel like a daily battle filled with uncertainty. Negative self-talk about this disease and its limitations ...

This episode of The Expert Series explores the complex relationship between lupus and fibromyalgia, focusing on definitions, symptoms, overlapping conditions, treatment approaches, mental health ...

An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of B-cell mediated autoimmune diseases, including systemic lupus erythematosus ...

If your child has lupus, this template letter can help you schedule a meeting with the school to educate their teachers and counselors about lupus and discuss a plan so your child can stay healthy and ...